Walgreens Pumps $418 Million Into China's Top Pharmacy Chain

The NYSE listed company saw a recent bid of $23.055 and 3897067 shares have traded hands in the session. Walgreens Boots Alliance, Inc.'s P/E ratio is 18.58. We see here that Walgreens Boots Alliance, Inc. This buyback authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases.

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company. The ERP5 of Walgreens Boots Alliance, Inc. The stock has "Buy" rating by Zacks on Monday, August 24. Reilly Financial Advisors LLC grew its position in shares of Walgreens Boots Alliance by 7.9% in the second quarter. The stock has performed -2.85% over the last seven days, 4.95% over the last thirty, and -14.16% over the last three months. Finally, American Century Companies Inc. lifted its stake in Walgreens Boots Alliance by 1,145.3% in the 2nd quarter. The stock decreased 0.65% or $1.46 during the last trading session, reaching $223.49.

Walgreens Boots Alliance Inc (NASDAQ:WBA) traded up $0.87 during trading on Wednesday, hitting $71.05. Walgreens Boots Alliance, Inc. During the same quarter in the previous year, the company earned $1.07 earnings per share. (NASDAQ:WBA)'s performance this year to date is -15.20%. (NASDAQ:WBA)'s RSI (Relative Strength Index) is 47.39. The company had revenue of $30.15 billion during the quarter, compared to analyst estimates of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Over the last six months, Walgreens Boots Alliance, Inc.'s stock has been -13.85% and -17.44% for the year. During the same period past year, the firm posted $1.07 EPS. (NASDAQ:WBA) rating on Monday, November 16. Creditors will loan money at a cheaper rate to a profitable company than to an unprofitable one; consequently, profitable companies can use leverage to increase stockholders' equity even more. (NasdaqGS:WBA) is 0.033538. This percentage is calculated by adding the dividend yield plus the percentage of shares repurchased. Walgreens Boots Alliance's dividend payout ratio is presently 42.33%. Shares buyback programs are typically an indication that the company's leadership believes its stock is undervalued. RSI is a technical indicator of price momentum, comparing the size of recent gains to the size of recent losses and establishes oversold and overbought positions. The target price per share by Deutsche Bank suggests upside of 10.43 % from the last price. (NasdaqGS:WBA) for last month was 1.09178. Loop Capital initiated coverage on Walgreens Boots Alliance in a report on Thursday, August 24th. The stock of Gem Diamonds Limited (LON:GEMD) earned "Buy" rating by FinnCap on Wednesday, August 19. As per Wednesday, October 28, the company rating was upgraded by RBC Capital Markets. The rating was maintained by Needham with "Buy" on Tuesday, November 21.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $85.89, for a total transaction of $234,995.04. Following the purchase, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Wellington Management Group LLP raised its position in shares of Walgreens Boots Alliance by 5.9% during the first quarter. If you are reading this news story on another domain, it was stolen and republished in violation of United States and global copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.truebluetribune.com/2017/12/07/walgreens-boots-alliance-inc-wba-stake-lessened-by-sprucegrove-investment-management-ltd.html.

GuoDa, which operates and franchises 3,500 retail pharmacies across 70 cities in China, said the Walgreens investment would help its nationwide expansion plans. The Company's products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Related Articles